hiv treatment

Australia’s Therapeutic Goods Administration has approved Juluca, a two-drug, single pill for HIV that advocates have welcomed as a “step forward” for Australians living with HIV. Juluca, which is a combination of dolutegravir and rilpivirine, is the first fixed-dose combination of a two-drug regimen for the treatment of certain adults with human immunodeficiency virus infection …